Fever and Antipyretic Supported by Traditional Chinese Medicine: A Multi-Pathway Regulation

Author:

Ma Le-Le,Liu Hui-Min,Luo Chuan-Hong,He Ya-Nan,Wang Fang,Huang Hao-Zhou,Han Li,Yang Ming,Xu Run-Chun,Zhang Ding-Kun

Abstract

The coronavirus disease, 2019 (COVID-19), has spread rapidly around the world and become a major public health problem facing the world. Traditional Chinese medicine (TCM) has been fully committed to treat COVID-19 in China. It improved the clinical symptoms of patients and reduced the mortality rate. In light of the fever was identified as one of leading clinical features of COVID-19, this paper will first analyze the material basis of fever, including pyrogenic cytokines and a variety of the mediators of fever. Then the humoral and neural pathways of fever signal transmission will be described. The scattered evidences about fever recorded in recent years are connected in series. On this basis, the understanding of fever is further deepened from the aspects of pathology and physiology. Finally, combining with the chemical composition and pharmacological action of available TCM, we analyzed the mechanisms of TCMs to play the antipyretic effect through multiple ways. So as to further provide the basis for the research of antipyretic compound preparations of TCMs and explore the potential medicines for the prevention and treatment of COVID-19.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference167 articles.

1. Temperature-elevating effect of a substance obtained from polymorphonuclear leucocytes;Beeson;J. Clin. Invest.,1948

2. Interferon-gamma: a historical perspective;Billiau;Cytokine Growth Factor. Rev.,2009

3. Cytokines, PGE2 and endotoxic fever: a re-assessment;Blatteis;Prostag. Oth. Lipid Mediat.,2005

4. Afferent pathways of pyrogen signaling;Blatteis;Ann. N. Y Acad. Sci.,1998

5. Pyrogen sensing and signaling: old views and new concepts;Blatteis;Clin. Infect. Dis.,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3